Lung volumes predict survival in patients with chronic lung allograft dysfunction

被引:35
|
作者
Kneidinger, Nikolaus [1 ]
Milger, Katrin [1 ]
Janitza, Silke [2 ]
Ceelen, Felix [1 ]
Leuschner, Gabriela [1 ]
Dinkel, Julien [3 ]
Koenigshoff, Melanie [4 ]
Weig, Thomas [5 ]
Schramm, Rene [6 ]
Winter, Hauke [7 ]
Behr, Juergen [1 ]
Neurohr, Claus [1 ]
机构
[1] Univ Munich, German Ctr Lung Res DZL, Comprehens Pneumol Ctr CPC M, Dept Internal Med 5, Marchioninistr 15, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Dept Med Informat Biometry & Epidemiol, Munich, Germany
[3] Univ Munich, German Ctr Lung Res DZL, Comprehens Pneumol Ctr CPC M, Inst Clin Radiol, Munich, Germany
[4] German Ctr Lung Res DZL, Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr CPC M, Res Unit Lung Repair & Regenerat, Munich, Germany
[5] Univ Munich, Dept Anaesthesiol, Munich, Germany
[6] Univ Munich, Clin Cardiac Surg, Munich, Germany
[7] Univ Munich, Dept Thorac Surg, Munich, Germany
关键词
BRONCHIOLITIS OBLITERANS SYNDROME; THIN-SECTION CT; COMPUTED-TOMOGRAPHY; RISK-FACTORS; TRANSPLANTATION; HYPERINFLATION; MORTALITY; ONSET;
D O I
10.1183/13993003.01315-2016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Identification of disease phenotypes might improve the understanding of patients with chronic lung allograft dysfunction (CLAD). The aim of the study was to assess the impact of pulmonary restriction and air trapping by lung volume measurements at the onset of CLAD. A total of 396 bilateral lung transplant recipients were analysed. At onset, CLAD was further categorised based on plethysmography. A restrictive CLAD (R-CLAD) was defined as a loss of total lung capacity from baseline. CLAD with air trapping (AT-CLAD) was defined as an increased ratio of residual volume to total lung capacity. Outcome was survival after CLAD onset. Patients with insufficient clinical information were excluded (n=95). Of 301 lung transplant recipients, 94 (31.2%) developed CLAD. Patients with R-CLAD (n=20) and AT-CLAD (n=21), respectively, had a significantly worse survival (p<0.001) than patients with non-R/AT-CLAD. Both R-CLAD and AT-CLAD were associated with increased mortality when controlling for multiple confounding variables (hazard ratio (HR) 3.57, 95% CI 1.39-9.18; p=0.008; and HR 2.65, 95% CI 1.05-6.68; p=0.039). Furthermore, measurement of lung volumes was useful to identify patients with combined phenotypes. Measurement of lung volumes in the long-term follow-up of lung transplant recipients allows the identification of patients who are at risk for worse outcome and warrant special consideration.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Update on Chronic Lung Allograft Dysfunction
    Gauthier J.M.
    Hachem R.R.
    Kreisel D.
    Current Transplantation Reports, 2016, 3 (3) : 185 - 191
  • [22] ALEMTUZUMAB FOR CHRONIC LUNG ALLOGRAFT DYSFUNCTION
    Girgis, Reda
    Sathiyamoorthy, Gayathri
    McDermott, Jennifer
    Lawson, Cameron
    Kumar, Anupam
    Hadley, Ryan
    Leacche, Marzia
    Murphy, Edward
    CHEST, 2020, 158 (04) : 2388A - 2388A
  • [23] PATTERNS OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION
    Herrera, V. Arias
    Sen, B.
    Huppmann, P.
    Ihle, F.
    von Wulffen, W.
    Baezner, C.
    Carolin, S.
    Hatz, R.
    Peter, U.
    Meiser, B.
    Neurohr, C.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 5 - 5
  • [24] Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival
    Newton, Chad A.
    Kozlitina, Julia
    Lines, Jefferson R.
    Kaza, Vaidehi
    Torres, Fernando
    Garcia, Christine Kim
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (08): : 845 - 853
  • [25] Primary Graft Dysfunction Increases the Risk of Baseline Lung Allograft Dysfunction but Not Chronic Lung Allograft Dysfunction after Lung Transplantation
    Li, D.
    Hirji, A.
    Weinkauf, J. G.
    Lien, D. C.
    Kapasi, A. M.
    Halloran, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S327 - S327
  • [26] Validation of a Blood Gene Signature to Predict Chronic Allograft Dysfunction in Lung Transplantation
    Danger, R.
    Durand, E.
    Foureau, A.
    Claustre, J.
    Roux, A.
    Le Pavec, J.
    Coiffard, B.
    Renaud-Picard, B.
    Mornex, J.
    Demant, X.
    Reynaud-Gaubert, M.
    Magnan, A.
    Tissot, A.
    Brouard, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S355 - S356
  • [27] BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients
    Berastegui, Cristina
    Gomez-Olles, Susana
    Sanchez-Vidaurre, Sara
    Culebras, Mario
    Monforte, Victor
    Lopez-Meseguer, Manuel
    Bravo, Carlos
    Ramon, Maria-Antonia
    Romero, Laura
    Sole, Joan
    Cruz, Maria-Jesus
    Roman, Antonio
    CLINICAL TRANSPLANTATION, 2017, 31 (03)
  • [28] Everolimus Treatment for Chronic Lung Allograft Dysfunction in Lung Transplantation
    Iturbe-Fernandez, David
    Gafas, Alicia de Pablo
    Cuesta, Victor Manuel Mora
    Moralejo, Rodrigo Alonso
    Loaiza, Carlos Andres Quezada
    Perez Gonzalez, Virginia
    Lopez-Padilla, Daniel
    Cifrian, Jose M.
    LIFE-BASEL, 2024, 14 (05):
  • [29] Montelukast in chronic lung allograft dysfunction after lung transplantation
    Vos, Robin
    Vanden Eynde, Ruben
    Ruttens, David
    Verleden, Stijn E.
    Vanaudenaerde, Bart M.
    Dupont, Lieven J.
    Yserbyt, Jonas
    Verbeken, Eric K.
    Neyrinck, Arne P.
    Van Raemdonck, Dirk E.
    Verleden, Geert M.
    Godinas, Laurent
    Van Herck, Anke
    Vanstapel, Arno
    Sacreas, Annelore
    Kaes, Janne
    Heigl, Tobias
    Ordies, Sofie
    Schaevers, Veronique
    De Leyn, Paul
    Coosemans, Willy
    Nafteux, Philippe
    Decaluwe, Herbert
    Van Veer, Hans
    Depypere, Lieven
    Frick, Anna E.
    Ceulemans, Laurens J.
    Weynand, Birgit
    Emonds, Marie-Paule
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (05): : 516 - 527
  • [30] Pharmacotherapy of chronic lung allograft dysfunction post lung transplantation
    Evans, Rickey A.
    Walter, Krysta S.
    Lobo, Leonard Jason
    Coakley, Raymond
    Doligalski, Christina T.
    CLINICAL TRANSPLANTATION, 2022, 36 (08)